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Abstract 
The opioid crisis continues to be a public health concern.  Traditionally, an opioid-centric 
approach treats postoperative pain.  The following PICOT question guided this project:  Will 
initiating a multimodal analgesic virtual reality quality improvement program (I) compared to 
current practice (C) decrease opioid requirements (O) in robotic hysterectomy patients (P) during 
the postoperative period (T)?  Several articles promote non-opioid analgesia and non-
pharmacological interventions, such as multimodal analgesia and virtual reality (VR) for pain 
management.  This project reviewed pre- and post-implementation data after implementing new 
evidence-based multimodal analgesia and VR protocols.  The project captured a total of 64 
patients in the pre-implementation group.  A total of 22 patients received both multimodal 
analgesia and VR in the post-implementation group.  There was no statistically significant 
difference in total opioid consumption converted as morphine milligram equivalents (MME) 
between the pre-implementation and post-implementation groups.  However, there was a 
statistically significant difference in multimodal analgesia administered in Pre-op between the 
pre-implementation and post-implementation groups.  In conclusion, the execution of the 
multimodal analgesic VR program allowed for nursing adoption of novel evidence-based 
practices (EBP) and promoted the use of non-opioid and non-pharmacological interventions.  
Although the combination of multimodal analgesia and VR did not reduce opioid consumption, 
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A Multimodal Analgesic and Virtual Reality Program to Reduce Opioid Exposure  
 Federal involvement in combatting the national opioid crisis began in the 1970s when 
Title II of the Comprehensive Drug Abuse Prevention and Control Act was passed (Gross & 
Gordon, 2019).  This act, also known as the Controlled Substances Act (CSA), required federal 
regulation of controlled substances and included formal recommendations for scheduling 
substances related to their potential for abuse (United States Drug Enforcement Act, n.d.).  Both 
cultural changes and prescribing patterns detrimentally evolved during the 1990s (Baker, 2017) 
as healthcare accreditors began tethering patient satisfaction to the frequency of clinician pain 
management interventions (Ashburn & Fleisher, 2016).  Between 1991 to 2013, the number of 
prescribed medications increased from 76 million to 97 million, an upward spiraling trend that 
may have been caused by the Food and Drug Administration’s (FDA) release of OxyContin 
(Baker, 2017).  OxyContin's manufacturers aggressively marketed towards high-prescribing 
physicians and released information that the medication was best suited for the treatment for 
non-cancer-related pain due to its low-risk for iatrogenic addiction (Zee, 2009).  It was not until 
2010 that the Affordable Care Act (ACA) required the Department of Health and Human 
Services (HHS) to declare pain as a public health concern (“Relieving Pain in America,” 2016).   
In December 2015, clinical practice guidelines emerged on the management of 
postoperative pain from the American Pain Society, the American Society of Regional 
Anesthesia, the American Society of Regional Anesthesia and Pain Medicine, and the American 
Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and 
Administrative Council (Chou et al., 2015).  Among some of the strong recommendations 
included providing patient and family-centered preoperative education and planning, 
administering multimodal therapies (including non-pharmacological techniques), and utilizing 
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oral opioids versus intravenous (IV) opioids because of their superior effects on postoperative 
pain.  
With the call to change health care culture from opioid-centric to opioid-sparing, a 
concerted effort from perioperative clinicians is required to manage postoperative pain optimally.  
In one study, 10% of opioid naïve patients undergoing short-stay or same-day surgery and given 
low-dose opioid prescription for pain became long-term opioid users after one year (Alam, 
Gomes, Zheng, Mamdani, Juurlink, & Bell, 2012).  Therefore, limiting the exposure during the 
immediate postoperative period may impact patient opioid usage in the long-run.   
Making a difference globally, nationally, and at the state level to formally fight against 
the opioid epidemic requires strategic planning and ongoing commitment.  One hospital in 
Southern California equipped its perioperative staff with virtual reality (VR), an innovative, 
disruptive technology.  According to one meta-analysis, the authors concluded that VR is a 
useful pain management tool that reduces acute pain during medical procedures (Mallari, Spaeth, 
Goh, & Boyd, 2019).  The purpose of this Doctor of Nursing Practice (DNP) project is to 
evaluate the implementation of a structured multimodal analgesic and virtual reality program to 
decrease opioid exposure and usage while effectively managing postoperative pain. 
Significance of the Practice Problem 
Millions of surgeries occur every year to heal or save lives (Meara et al., 2016).  
Unfortunately, the prevalence of poorly controlled postoperative pain due to adverse events 
continues to be the unresolved reality for many patients.  The estimated cost to healthcare 
organizations is US $1,869±4,553 per patient (Gan, 2017).  According to the Institute of 
Medicine (IOM), patients report pain after surgery 80% of the time, with varying levels ranging 
from moderate to severe and extreme (IOM, 2011).  To address postoperative pain, surgeons 
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prescribe analgesic medications after surgery (Gan, Epstein, Leone-Perkins, Salimi, Iqbal, & 
Whang, 2018).  Commonly, these medications include IV opioids such as morphine, 
hydromorphone, and fentanyl.  One study by Gan et al. (2018) found that 45% of physicians 
surveyed were not concerned with the patient’s risk of addiction in combination with acute usage 
of postoperative IV opioids.  In another study, 6% of patients continued to take opioids after 90 
days following both major and minor surgery (Brummet et al., 2017).  This research suggested 
that more than 2 million patients transition from acute to chronic opioid consumption every year.   
About 80% of heroin abuser’s habits stem from opioids prescribed by doctors (Adams, 
Bledsoe, & Armstrong, 2016).  Around 450,000 drug-related deaths were reported globally in 
2015, with 160,000 related to drug use overdose and 118,000 pertaining to opioid use disorders 
(World Health Organization [WHO], 2018).  In the United States, opioids caused more than half 
of the 70,200 drug overdose deaths reported in 2017, and about 130 Americans die from an 
opioid overdose daily (Centers for Disease Control [CDC], 2018).  In the same year, over 11.4 
million people abused their opioid prescriptions (U.S. Department of Health and Human Services 
[HHS], 2019).  Interestingly in California, most opioid-related deaths are from prescription 
opioids, compared to synthetic opioids and heroin (National Institute on Drug Abuse [NIDA], 
2019).   
Postoperative pain can result from nociceptive pain, or a neuronal response to noxious 
stimuli (Czarnecki & Turner, 2018).  Two types of nociceptive pain exist; somatic (localized, 
present in the skin, tissue, muscles, or bones) and visceral (diffuse, originating from deep inside 
the body).  Both peripheral and central sensitizing factors are the consequence of postoperative 
pain, which requires adequate control through various opioid and non-opioid techniques (Luo & 
Min, 2017).  Traditionally, an opioid-centric approach to postoperative pain management has 
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been used by clinicians (McEvoy et al., 2017).  However, several articles promote a shift in 
tactics through minimizing opioid analgesia and incorporating non-opioid treatment modalities 
(Chou et al., 2015; Jones, Viswanath, Peck, Kaye, Gill, & Simopoulous, 2018; McEvoy et al., 
2017).  
Patients undergoing total laparoscopic hysterectomies typically experience the most 
intense incisional and visceral pain 30 minutes after surgery, and the pain gradually decreases 
over time (Choi, Kang, Song, Seok, Kim, & Kim, 2016).  One study found that gynecologists 
prescribe two times the amount of opioids than the average consumption after a hysterectomy 
procedure and cite multifactorial reasons for this practice, such as patient satisfaction and 
reduced postoperative calls for refills (As-Sanie et al., 2017).  Within the last three years, the 
robotic approach to gynecological surgery has become the surgical standard (Wright, et al., 
2013), since the technology allows for easy adaptation from laparoscopic techniques (Lane, 
2018).  Surgeons appreciate the robotic approach for accuracy and precision because it allows for 
minimal invasiveness, an optimal field of view, and improved dexterity (Shah, Vyas, & Vyas, 
2014).  However, despite significant pain reduction with the robotic approach compared to the 
vaginal approach, morphine consumption remained the same in the recovery room in one study 
(Carbonnel et al., 2013).  This suggests opioid-centric clinician culture persists despite improved 
outcomes.   
PICOT Question 
The following PICOT question guided this project:  Will initiating a multimodal 
analgesic virtual reality quality improvement program (I) compared to current practice (C) 
decrease opioid requirements (O) in robotic hysterectomy patients (P) during the postoperative 
period (T)?  
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During a post anesthesia care unit (PACU) chart audit, robotic hysterectomy patients 
consumed the second-highest amounts of opioids in the recovery room.  This population was 
chosen to best control the environment during the project pilot due to their high volumes of 
surgeries each week and outpatient status.  Implementing a standardized multimodal 
postoperative analgesic protocol has been shown to improve pain management and reduce opioid 
consumption (Walker et al., 2019).  Therefore, this project compared the new implementation of 
a multimodal analgesic virtual reality program against current unstandardized pain management 
practices and measured the total opioid administration converted as morphine milligram 
equivalents (MME).  The definition of the postoperative period includes the time the patient is 
admitted to the PACU (including both Phase 1 and Phase 2) until the patient is discharged home.    
Framework of the Problem 
Framework 
In the clinical setting, the PDSA cycle tests change and allows stakeholders to adopt new 
knowledge quickly (Picarillo, 2018).  The Associates in Process Improvement cofounders further 
expanded the model to answer three questions and named it the Model for Improvement (Crowl, 
Sharma, Sorge, & Sorensen, 2015; Joshi, Ransom, Nash, & Ransom, 2014).  The questions 
included: (1) What are we trying to accomplish?, (2) How will we know that a change is an 
improvement?, and (3) What change can we make that will result in improvement?  The Model 
for Improvement was used as the framework to implement this DNP Project.  It provided the 
structure for the project to positively impact clinical outcomes, organizational costs, and 
productivity (Crowl et al., 2015).   
 The Model for Improvement helped define this project’s aims and outcomes (Crowl et 
al., 2015) and established a SMART (specific, measurable, attainable, realistic, and timely, [Dye, 
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2017]) goal.  By providing virtual reality as a non-pharmacological intervention, can nurses 
decrease opioid exposure by 10% (a hospital executive goal) within the patient’s recovery 
period?  Multimodal analgesia, also known as providing the patient with two or more drugs or 
interventions that provide analgesic relief (American Society of Anesthesiologists Task Force, 
2012), is today’s standard (Mariano & Schatman, 2019).  This concept is an integral component 
of enhanced recovery after surgery (ERAS) protocols (Montgomery & McNamara, 2016; 
Pogatzki-Zahn, Segelcke, & Schug, 2017; Tan, Law, & Gan, 2014), something already 
established at the hospital of study.  Therefore, to answer the second question, this project would 
need to show decreased opioid administration and an increase in multimodal techniques to 
benefit the patient’s surgical experience.  The third question, “What change can we make that 
will result in improvement?” will be answered by focusing on a specific patient population 
(Crowl et al., 2015) that will benefit the most from this program.  
Change Theory 
 Everett Roger’s Diffusion of Change Theory is the foundation of this project as it 
describes the process of adopting innovations in healthcare (Dearing & Cox, 2018).  Dearing & 
Cox (2018) defined diffusion as a social process among organizational stakeholders resulting 
from an evidence-based, innovative change.  The process is dependent on when the change is 
adopted and accelerated by the perceived relative advantage (Lundblad, 2003).  If the 
stakeholders’ values align with the project’s mission, there is greater compatibility and 
trialability.  Every individual’s needs vary and affect their appraisal of the innovation’s 
advantages and disadvantages (Dearing & Cox, 2018).  
Evidence Search Strategy 
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To most effectively explore multimodal pain management and virtual reality, an 
exhaustive systematic review of the literature occurred.  The search included the following 
Medical Subject Headings (MESH) terms: “pain management,” “pain management/methods,” 
“pain, postoperative,” “analgesics, non-narcotic,” and “virtual reality.”  Databases used to 
conduct the search included CINAHL, EBSCO, ProQuest, and PubMed and included only 
primary sources.  The following inclusion criteria were applied: (1) participants studied ≥ 18 
years of age, (2) multimodal and/or non-pharmacologic approach to pain management, (3) 
articles written in English, (4) articles published within the last five years (2015-2020).  
Exclusion criteria included (1) participants studied < 18 years of age, (2) opioid approach to pain 
management, (3) non-English articles, (4) secondary sources, and (5) articles published more 
than five years ago.   
The foundations of multimodal and non-pharmacologic approaches to pain management 
helped find superior methods compared to high-dose opioid administration.  Articles were 
retained if they were relevant and less than five years old.  Duplicated articles were eliminated.  
After applying the inclusion and exclusion criteria, 13 articles were chosen; 6 articles were based 
on multimodal analgesia, and 7 pertained to virtual reality as a non-pharmacological 
intervention.     
Evidence Search Results and Evaluation 
A review of the literature allowed for an extensive exploration of evidence-based 
practices (EBPs) to help create a multimodal analgesic VR program.  An initial search using the 
Boolean operator “AND,” as well as the MESH terms “pain management,” “pain 
management/methods,” “pain postoperative,” and “analgesics, non-narcotic” produced 57 
articles.  Searching the MESH terms “virtual reality” and “pain management” with the Boolean 
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operator “AND” resulted in 29 articles.  The initial search resulted in a total of 86 articles.  After 
completing a review of the abstracts and inclusion and exclusion criteria were applied, a 
thorough examination of 19 articles commenced.  A total of 6 articles were removed due to 
secondary research and protocol-only designs, and a sum of 13 articles emerged for synthesis.  
See the PRISMA Flow Diagram in Figure 1. 
One reviewer analyzed the articles in a standardized manner and utilized the Johns 
Hopkins Nursing Evidence-Based Practice Appraisal Tool to consider the literature's level of 
evidence and quality.  Types of studies retained included retrospective cohort studies, quasi-
experimental research, randomized control trials, randomized comparative effectiveness trials, 
non-experimental correlational research, and meta-analysis/systematic reviews.  The level of 
evidence ranged from I-V (2 level I, 3 level II, 4 level III, and 3 level V).  The majority of 
articles received a “Good” to “High” quality grade.  Only one study was deemed “Low” quality 
due to insufficient data analysis information.  One randomized controlled trial and three 
systematic reviews added strength to the evidence found.  
Themes from the Evidence 
The literature review identified the general characteristics of a successful pain 
management program.  A synthesis matrix developed contrasting concepts and underlying ideas 
(see both Appendix and B).  Similar themes included multimodal analgesia, clinician culture 
related to pain management, the benefits of reducing opioids in the perioperative period, and 
virtual reality as a non-pharmacological intervention.   
Multimodal Analgesia 
 Several studies support the use of non-opioid analgesics (acetaminophen, NSAIDs, COX-
2 inhibitors, and gabapentin/pregabalin) both preoperatively and postoperatively to improve pain 
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management (Cozowics et al., 2019, Smith, Young, Blosser, & Poole, 2019; Desai et al., 2018; 
Militsakh et al., 2018; Brandal et al., 2017; Brubaker, Kendall, & Reina, 2016).   One high-
quality retrospective cohort study saw a substantial reduction in opioids as COX-2 inhibitors and 
NSAIDs were administered (Cozowics et al., 2019).  Contrastingly, another good quality 
retrospective cohort study found that as acetaminophen use per day increased in combination 
with NSAID administration, the primary outcome of median morphine milligram equivalents 
administered reduced (Smith et al., 2019).    
Adverse effects were significantly reduced as a result of less opioid usage, which 
included a decrease in postoperative ventilation, critical care admission, obstructive sleep apnea 
(OSA), gastrointestinal complications (i.e., ileus; Cozowics, 2019), and decreased lengths of stay 
(Cozowics, 2019; Brandal et al., 2017).  Adversely, Cozowics (2019) also pointed out that 
genitourinary complications did not increase as a result of the non-opioids used, suggesting that 
renal toxicity is not a risk factor associated with multimodal analgesia.   
Clinician Culture 
 Healthcare providers can shift cultural perceptions to implement effective postoperative 
analgesia (Militsakh, 2018).  There is an associated learning curve with the adoption of new 
methods of practice.  Buy-in and adherence increase over time as clinicians denounce traditional 
perspectives of pain management.  Although reticence may act as a barrier, witnessing the 
positive effects of alternative analgesia administration greatly impacts clinician behavior.  
 While most studies allude to clinician awareness, one study highlighted physician 
behavior as a barrier to proper opioid management (Brandal et al., 2017).  Standard discharge 
order sets do not allow for customizable opioid prescribing; rather, they make it easier for 
physicians to order opioids on every patient.  The study suggested educating physicians to 
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modify prescribing behaviors by evaluating objective data more thoroughly and following 
clinical practice guidelines to minimize opioid prescribing.  
Reducing Opioids in the Perioperative Period 
 A similar theme throughout the literature revealed how the perioperative period creates 
an essential opportunity to stave chronic opioid usage since opioids are typically introduced to 
opioid-naïve patients postoperatively (Militsakh, 2018; Brandal et al., 2017).  It is evident that 
reducing the availability of opioids can impact the opioid epidemic positively (Militsakh, 2018).  
Integrating non-opioid approaches in the hospital can reduce the administration of opioids (Smith 
et al., 2019), thereby reducing exposure and exploitation of high-risk drugs.  
Virtual Reality  
 Similar to the non-opioid approaches, VR is a non-pharmacological intervention that can 
benefit patients’ pain with minimal side effects (Spiegel et al., 2019; Chan, Foster, Sambell, & 
Leong, 2018; Vazquez, Lara, Miller, Wiederhold, & Wiederhold, 2019; Glennon et al., 2018; 
Mohammad & Ahmad, 2018, Scapin, Echevarria-Guanilo, Junior, Goncalves, Rocha, & 
Coimbra, 2018).  The use of technology to distract the patient from their pain complements 
traditional pain management methods.  VR is a superior tactic compared to other mediums, such 
as television (Speigel et al., 2019) or music (Glennon et al., 2018).  The technology can treat 
acute pain intraoperatively or during medical procedures, but long-term carryover effects have 
not been proven (Mallari et al., 2019).  However, one study proved VR’s immediate pain 
reduction effects postoperatively (Glennon et al., 2018).  Nurses commonly utilize the 
technology within the literature (Spiegel et al., 2019; Mohammad & Ahmad, 2018; Scapin et al., 
2018), since it enhances their workflow, such as during painful dressing changes (Scapin et al., 
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2018).  While VR can be used to improve pain, it can also significantly reduce anxiety (Glennon 
et al., 2018; Mohammad & Ahmad, 2018). 
 Interestingly, one high-quality randomized comparative effectiveness trial found similar 
physician opioid prescribing practices in the study by Brandal et al. (2017), despite changes to 
pain management interventions (Spiegel et al., 2019).  The study found that usual practice and 
equivalent MME administration had higher pain scores than the VR group, providing evidence 
that changes to prescribing practices are needed. 
 There was a high risk of bias in the systematic review by Chan et al. (2018).  Many 
studies lacked prospective enrollment and rigorous adherence to CONSORT guidelines.  It is 
also challenging to blind a participant to VR as an intervention.  Therefore, future high-quality 
studies should be conducted to confirm the effects of VR.  
 The findings from this literature are multifaceted and recommend implementing multiple 
non-opioid medications or non-pharmacologic interventions, such as VR, to improve pain 
management from a nursing perspective.  A primary limitation of this review included a lack of 
randomized control trials to recommend multimodal analgesia and virtual reality strongly.  Most 
of the studies supported further research in various clinical settings.   
Practice Recommendations 
 Based on a thorough review of the literature, the documentation supports a multifactorial 
approach to pain management in the form of both non-opioid and non-pharmacological 
interventions.  It is strongly recommended with moderate-quality evidence to incorporate 
acetaminophen, NSAIDs, COX-2 inhibitors, and gabapentin/pregabalin throughout the entire 
perioperative period (Cozowics et al., 2019, Smith, Young, Blosser, & Poole, 2019; Desai et al., 
2018; Militsakh et al., 2018; Brandal et al., 2017; Brubaker, Kendall, & Reina, 2016).  The 
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addition of VR to an analgesic regimen was also strongly recommended with moderate quality 
evidence to decrease pain (Spiegel et al., 2019; Chan, Foster, Sambell, & Leong, 2018; Vazquez, 
Lara, Miller, Wiederhold, & Wiederhold, 2019; Glennon et al., 2018; Mohammad & Ahmad, 
2018, Scapin, Echevarria-Guanilo, Junior, Goncalves, Rocha, & Coimbra, 2018).  Both practices 
improve pain management and contribute to higher patient satisfaction while reducing the risk of 
opioid-related adverse effects.  Therefore, these practice recommendations will be incorporated 
into this program. 
 Considering the Guidelines on the Management of Postoperative Pain, similar 
recommendations exist regarding multimodal therapies and cognitive-behavioral modalities.  The 
panel recommended combining treatments, utilizing both analgesic medications and non-
pharmacologic interventions as synergistic mechanisms of action to provide adequate pain relief 
(Chou et al., 2016).  Although the recommendation in the guidelines for cognitive-behavioral 
modalities is weak with moderate-quality evidence, they are noninvasive, minimal risk 
interventions with positive effects on postoperative pain and anxiety. 
 There is strong evidence that supports patient and family-centered preoperative education 
and planning (Chou et al., 2016).  Customized programs for a heterogeneous patient population 
can improve postoperative opioid consumption by managing patient expectations and allowing 
autonomy in the decision-making process.  Also, the use of short-acting oral opioids versus IV 
opioids is strongly recommended with moderate-quality evidence.  Nevertheless, nurses should 
include discharge education on tapering, discontinuation, and proper disposal of opioids.  A 
visual Venn diagram highlights the structure of the Multimodal Analgesic Virtual Reality 
program (see Figure 2).  
Project Setting 
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This DNP EBP change project took place in a large, nonprofit acute-care community 
hospital located in Southern California.  As one of the largest hospitals in Orange County, its 
mission is to provide the highest quality care to its surrounding communities as a trusted and 
nationally recognized health care leader with 588 licensed beds.  The population surrounding the 
hospital and its institutes includes close to 2 million residents, which comprises 21.9% 
children/youth, 63.9% adults, and 14.1% seniors.  The population’s ethnic backgrounds include 
White (46.4%), Hispanic or Latino (31.1%), Asian (18.1%), and other races (5.5%).  
The perioperative environment consists of three nursing units: Preoperative/Same-Day-
Services Unit (SDS), Operating Room (OR), and Post Anesthesia Care Unit (PACU).  
Implementation of the project occurred on the second-floor pavilion with six dedicated OR 
suites.  Both the Pavilion SDS and PACU have twelve patient bays with up to six nurses staffing 
each unit, depending on the caseload, acuity levels, and census.   
Needs Assessment 
In January 2020, the hospital gained recognition as a Center of Excellence in Robotic 
Surgery.  However, a needs assessment and practice gap analysis revealed that the robotic 
hysterectomy patients were the second-highest consumers of opioids in the PACU compared to 
other procedures.  Based on the population’s opioid consumption and outpatient status, the 
robotic hysterectomy patient population became the project’s participant pool.  Since most 
patients discharge on the same day of surgery, the program’s effectiveness was closely measured 
within the PACU clinical setting.  A chart audit included 64 patients, which calculated the total 
opioid consumption in both PACU Phase I and Phase II.  This data and preoperative prescribing 
practices were taken to the hospital’s Chief Executive Officer (CEO), Chief Nursing Officer 
(CNO), Chief of Strategy, and Perioperative Executive Leadership.  Organizational support was 
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achieved based on opioid administration in the PACU and the strategic goal of implementing 
new technologies within the hospital.  The DNP project was approved and allowed to move 
forward.  A SWOT Analysis highlighted the internal and external forces that may impact 
implementation (see Figure 3).  Plans for sustainability included testing the program in a 
microclimate to gain buy-in from stakeholders involved with the project.  Executive leadership 
supported the idea of scaling virtual reality into all areas of patient care, as well as strategizing to 
accomplish a new hospital designation called “Opioid Safe Hospital Designation,” if the program 
demonstrates emerging success.   
Project Overview 
The project's mission was to replace the opioid-centric nursing and physician culture with 
opioid-sparing techniques to improve pain management and reduce adverse side effects.  The 
project's vision addressed the organization’s intention to become a dominant competitor in the 
immersive extended realities (XR) market.  A 10% reduction of total opioid consumption before 
patient discharge from PACU deemed the project's success.  A full risk assessment (see Figure 4) 
and management plan addressed issues, such as nausea and vomiting during VR usage, fall risk, 
or disruption of clinician workflows.  Labeled strategies guided the stakeholders to transfer, 
accept, mitigate, or eliminate the risks (Kogon, Blakemore, Wood, 2015).  The impact and 
probability scores ranked the level of influence each risk may play.  A subsequent written plan 
included communication with specific stakeholders who could support the process and manage 
solutions.  This was communicated to all nurses during their training.   
Objectives 
The organization’s Pavilion PACU was the primary setting for the project where the 
majority of patients recover in Phase I and transition to Phase II without leaving the department.  
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The nursing unit consisted of 12 patient bays and a nursing ratio of 1:2 patients, depending on 
the patient's acuity level and type of surgery.  Up to 6 nurses employed the unit at one time, 
flexing with the census and level of care that patients required.  On any given weekday, 1-6 
robotic hysterectomy patients underwent surgery, which allowed for an adequate participant 
selection.  The short-term objective was for clinicians to adhere to protocol guidelines during the 
project pilot.  The long-term objective was for clinicians to adopt the practices into their 
everyday workflow to optimally care for every surgical procedure in a standardized manner. 
Stakeholders’ Roles 
 The DNP student played a vital role as the project lead.  Clinical leadership was critical 
to facilitate interdisciplinary collaboration and drive change at the nursing bedside (Bender, 
Connelly, & Brown, 2012).  The project lead facilitated perioperative nursing, anesthesiologist, 
and surgeon education.  Each healthcare provider maintained a role that was imperative for 
project success.  The surgeon oversaw all care provided from beginning to end.  Their buy-in 
was crucial to help support the program and its mission.  The anesthesiologists oversaw all 
medications given during the perioperative period.  Their role was to write specific doctor’s 
orders limiting IV opioids and promoting both non-opioid medications and non-pharmacological 
techniques.  The preoperative nurses were in charge of recruiting participants and educating them 
about the new program.  The intraoperative nurses drove communication about the project to the 
postoperative period, where the PACU nurse initiated the multimodal analgesic virtual reality 
program’s pain management protocols.   Interprofessional communication amongst all 
stakeholders was the foundation of the project’s effectiveness (Busari, Moll, & Duits, 2017).    
Project Plan (Method) 
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The Model for Improvement guided the DNP Project and allowed stakeholders to 
understand how the project measured success and identified opportunities for improvement.  The 
model required a PDSA cycle, a tool to test rapid improvements for both small and large-scale 
projects (Picarillo, 2018).  The team was engaged and learned from the project, which allowed 
for acceptance or rejection of refined workflows.  The knowledge attained affected the system 
globally as adoption spread to other areas of the hospital.  The project lead was the DNP student.  
The nursing preceptor, nursing researcher, and physician champions were the project mentors.  
The Planning Stage occurred from October-May 2020.  The Do Stage took place during the first 
week of June 2020.  The Study Stage commenced from the second week of June and ran until the 
end of July 2020.  Lastly, the Act Stage, or project wrap-up, occurred during August-December 
2020.  The PDSA cycle and full details regarding the Multimodal Analgesic Virtual Reality 
program are outlined below.  See Appendix C for the full project schedule.  
Planning Stage 
The Planning Stage took place from October 2019 to June 2020.  This program's structure 
was developed based on the literature review and enhanced with both physician and nurse 
feedback.   Interdisciplinary collaboration guided decision-making for specific practice changes.  
The latest evidence-based recommendations for perioperative pain management were embedded 
within the program.  The DNP student partnered with an anesthesiologist, surgeon, and nursing 
Unit Practice Council to help form clinician education and medication administrative practices.   
The Director of Extended Reality Therapeutics, the project’s sponsor, decided back in 
November 2019 to partner with AppliedVR.  This company supports the delivery of safe and 
effective VR therapeutic technologies by treating health conditions with evidence-based, non-
invasive, and opioid-sparing interventions (AppliedVR, 2019).  Since the company was awarded 
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a grant by the National Institute on Drug Abuse (NIDA) for more than $2.9 million to study VR 
for both acute and chronic pain, it was an easy decision to utilize their technology for the 
organization’s patient care needs.  The equipment supplied by the company includes the PICO 
G2 4K HMD with SootheVR programming, as well as technical support available during regular 
business hours, Monday through Friday.   
The business proposal for formal implementation and budgetary requirements was 
presented to the CEO, CNO, and Chief Strategy Officer back in February 2019.  The budget is 
outlined in Figure 5.  After attaining approval, a plan to reach the stakeholders involved with the 
project was created.  The DNP nurse created a presentation curated for each healthcare provider 
group, including the nurses, anesthesiologists, and gynecology-oncology surgeons.  Approval 
from each group was granted in May 2020.  
Preoperative Setting 
 During the preoperative period, nurses were responsible for recruiting participants based 
on the inclusion and exclusion criteria (see Figure 6), and participants were chosen based on 
convenience and opportunity recruitment.  Only Hospital Ambulatory Surgical (HAS) patients 
were included in the program due to their same-day discharge disposition.  Surgical admit 
patients were excluded.  The nurse introduced the VR head-mounted displays (HMDs) and 
instruction pamphlet (see Figure 7) to the patients if the criteria were met.  Preoperative 
education was conducted on how to use the HMDs in the postoperative period after surgery.  
Pain management expectations were addressed by establishing goals for future pain medication 
administration.  The patients trialed the HMD for about 5 minutes, allowing them to navigate the 
simulations and pick between guided-meditation, guided imagery, or interactive games.  An 
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established time limit ensured operating room (OR) delays did not occur.  If time allowed, 
patients were allowed to utilize the HMDs for more extended periods.   
 Anesthesiologists and surgeons were held accountable for ordering at least two 
preoperative multimodal analgesic medications, including the combination of acetaminophen, 
NSAIDs, COX-2 inhibitors, and gabapentin/pregabalin.  The ordering practices depended on 
physician preference.  Preoperative nurses were in charge of executing the orders and 
administering the medications to the patients prior to surgery. 
Postoperative Setting 
The World Health Organization’s (WHO) Pain Relief Ladder served as the framework 
for pain medication administration in the PACU (see Figure 8).  As an ethical consideration, 
opioids were not withheld from the patients—nurses administered medications based on the pain 
relief ladder.  For patients who complained of pain on admission on a Numeric Rating Scale 
(NRS) 7-10/10, an opioid rescue plan was implemented, and IV opioids were administered to 
treat severe pain.  For patients who complained of pain on a scale from 1-6/10, VR was utilized 
as a non-pharmacological intervention.  Oral opioids (i.e., Norco, Percocet, or Roxicodone), in 
combination with tramadol and other non-opioid analgesics such as Toradol or Robaxin, were 
considered for patients who complained of pain on a scale from 5-6/10.  Oral acetaminophen was 
administered for patients who complain of pain from 1-4/10.   
Since the patients were not appropriate for oral medications immediately after surgery 
due to the risk of nausea and vomiting, they received both IV medications and VR as a non-
pharmacological intervention until they were optimized for oral medications.  Administration of 
IV opioids followed EPIC order set instructions to administer the lowest dose initially.  The 
order also limited administration if the patient met opioid-naïve criteria.  If the patient was 
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opioid-tolerant (used opioids for one week or longer or around-the-clock use is present of at least 
the following daily dose: 60 mg oral morphine, 60 mg oral hydrocodone, 30 mg oral oxycodone, 
8 mg oral hydromorphone, fentanyl patch 25 mcg/hr, or the equivalent of another opioid), 
dosages increased to meet the needs of the patient following the initial lowest dose.  
A VR utilization log sheet accompanied the patient’s chart from the preoperative to 
postoperative setting (see Figure 9).  The sheet was blue and visually alerted the nurses that the 
patient was a project participant.  The preoperative nurse was responsible for writing in the 
patient’s unique medical record number (MRN) and answering two questions: (1) Did the patient 
receive VR training?, and (2) Did the patient receive oral multimodal (≥2) medications in Pre-
op?  If the answer to both questions was yes, the preoperative nurse checked the box.  Before the 
patient transferred to surgery, hand-off communication occurred between the preoperative and 
operating room nurses.  After the procedure was complete, the operating room nurse 
communicated with the PACU nurse and indicated that the patient was a participant in the 
multimodal analgesic virtual reality program.  PACU nurses admitted the patient to the nursing 
unit and ensured the patient was stable and cognitively appropriate for VR.  They used the VR 
utilization log sheet to document the times the patient was wearing the HMD.  A timer was set to 
ensure patients did not exceed 30 minutes.  The patient could use the headset an unlimited 
amount of times, as long as the session did not exceed 30 minutes total.  Nurses were allowed to 
make comments on the log.  For example, if the intervention was discontinued due to nausea, the 
nurses wrote this information in the comment section.  Once the patient was discharged or 
transferred, the log sheet was stored in a locked document box located on the nursing unit.  The 
project lead was the only team member with access to the locked box.  The information was 
transferred to a password-protected spreadsheet located on an encrypted, password-protected 
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USB flash drive.  After moving the data, the sheet was dropped into the organization’s document 
shred box.  
Do Stage 
The Do Stage took place during the first week of June 2020.  All perioperative nurses 
received a nursing in-service provided in small groups.  Attendance was required and supported 
by nursing executive leadership.  During this time, nurses had the opportunity to test-run the 
HMDs on the unit.  They had access to the equipment, and monitoring of proper cleaning and 
sanitizing procedures occurred.  Nurses were required to clean the HMD before and after each 
patient’s use with a PDI Sani-Cloth AF# Germicidal Disposable Wipe.  A dry optical lens 
microfiber cloth or soft gauze was used to clean the headset lens after being wiped with the Sani-
Cloth.  If the participant complained of any discomfort (i.e., eye strain, nausea, dizziness, or 
headache) during the intervention, including pain caused by the HMD itself, nurses were advised 
to discontinue the HMD immediately.  Appropriate care was provided based on the risk 
management plan presented during the nursing in-services.  
Study Stage 
 The Study Stage commenced during the second week of June and ran until the end of 
July 2020.  This stage marked the full project implementation phase.  To ensure stakeholder bias 
was not a factor and workflows were not impacted after the project announcement, the cohort of 
64 patients gathered during the needs assessment and practice gap analysis from January to 
March 2020 was utilized as the project’s historical pre-intervention group.  The program’s 
structure was applied to clinician workflows, and data collection on the post-intervention group 
was conducted throughout the Study Stage.  Data analysis variables were extracted from the 
EPIC electronic health record (EHR) and stored in a password-protected spreadsheet located 
A MULTIMODAL ANALGESIC VIRTUAL REALITY PROGRAM      22 
within an encrypted USB flash drive.  A validated opioid calculator, known as the GlobalRxPh 
Opioid Conversions Calculator, was used to convert all IV and oral opioids to an equianalgesic 
form of oral morphine milligram equivalents (MME).  
Act Stage 
 The Act Stage took place from August to December 2020.  A comprehensive evaluation 
of the program and extensive data analysis comparing the pre-intervention group to the post-
intervention was conducted.  The synthesis of evidence was critically appraised, and written 
recommendations were presented to the organization’s Executive Leadership team.   
Project Evaluation 
Evaluation Plan 
The project evaluation plan included comparing pre- and post-implementation data and 
analyzing if there was a statistically significant clinical difference.  An ad hoc selection method 
was used to recruit participants dependent on participant accessibility or proximity to the project 
(Jager, Putnick, Bornstein, 2017).  The collection of pre-implementation data on 64 participants 
occurred during June 2020 on patient charts with a date of surgery between January and March 
2020.  Post-implementation data was collected from the second week of June to the end of July 
2020.  The reliability and validity of the data collection process remained consistent since there 
was only one data collector who ensured the steps were streamlined and uniform.  Post-
implementation recruitment strategies included selecting participants according to inclusion and 
exclusion criteria (see Figure 6).  The nurses followed a process map algorithm to determine if 
the patient met the criteria.  The map walked the nurse through the requirements in a step-wise 
fashion.  Participants were selected if they were female, undergoing robotic hysterectomy 
outpatient surgery, English-speaking, and followed commands appropriately (no cognitive 
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deficits).  The participants were excluded if they were in isolation precautions, cognitively 
impaired, non-English speaking, had open wounds to the head or neck, or had a history of 
seizures or claustrophobia.    
Ethics, Human Subjects Protection, & Data Protection  
Ethics and human subjects’ protection were the project lead’s priority during the project.  
Careful consideration of all human subjects’ rights was completed during the proposal 
development.  The DNP student sought approval from both the EBP Committee (EPRC) from 
the University of St. Augustine for Health Sciences and the Institutional Review Board (IRB) 
from St. Joseph Hospital as required by the hospital’s policies and procedures.  All protected 
health information (PHI) was stored on an encrypted flash drive and stored in a locked container 
when not in use.  The project lead accessed the PHI via a password-protected hospital cloud.  
Another password was required to access the EPIC EHR.  The anonymity of data was maintained 
by transferring the data to a password-protected Excel spreadsheet, only accessible by the project 
lead.  This document was stored on the encrypted flash drive.  Patient names were not transferred 
nor published in an identifiable manner.  The hospital’s Health Insurance Portability and 
Accountability Act (HIPAA) Compliance Officer reviewed all data collection tools before 
implementing and after implementing the project, which included the data collection sets.  The 
project lead received approval at each stage.  
Variables 
 The project lead collected data on multiple variables from both pre- and post-
implementation participant groups.  The primary variable warranting program success and 
feasibility included total opioid consumption converted to MME administered in the PACU 
during Phase I and II until patient discharge.  The secondary variables included patient medical 
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record number (MRN), age, gender, race/ethnicity, body mass index (BMI), American Society of 
Anesthesiologists Classification (ASA), diagnosis, preoperative pain score, pain score at 
discharge, multimodal analgesia administered in Pre-op, length of stay (LOS) in PACU, and VR 
utilization time.  The overall evaluation plan outlined variable names, descriptions, data sources, 
the possible range of values, levels of measurement (nominal, ordinal, interval, or continuous), 
categories of measures, and timeframe for collection (see Appendix D). 
Power Analysis and Sample Size Determination 
A priori power analysis was conducted to determine the minimum number of participants 
required for the project for an 0.80 power of finding a statistically significant difference in the 
total opioid administration converted as MME between the multimodal analgesic VR program 
and current practice, using the two-sample t-test.  The 0.80 power for power analysis is the 
desired power of the test.  The power analysis for the two-sample t-test was performed using 
Gpower 3.1.9.4 (Faul, Erdfelder, Buchner, & Lang, 2009) to determine the minimum sample size 
needed for this project.  For a medium effect size of 0.5 (Cohen, 1988) and an alpha level = 0.05, 
the minimum sample size needed to achieve a .80 power was 128 participants (see Appendix E).  
Data Analysis  
Data were imported and analyzed using SPSS version 23 for Windows (IBM Corp., 
Armonk, NY).  Data were examined using frequency tables and descriptive statistics for 
missingness and data entry errors.  Participants with missing or erroneous data were excluded 
from data analysis, such as those who did not receive both multimodal analgesia in the 
preoperative area or those that refused VR in the PACU.  Frequency tables (for categorical 
variables) and descriptive statistics (for continuous variables) were used to summarize (1) 
participants’ demographics, including age, gender, race, BMI, ASA, and diagnosis warranting 
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procedure, (2) the event variables, included opioids prior to admission, preoperative pain 
score/level, multimodal analgesia administered in pre-op, pain at discharge, IV opioids 
administered in PACU, oral opioids administered in PACU, length of stay in PACU, and total 
VR utilization time (in minutes), and (3) the primary outcome variable, total opioid consumption 
converted as MME, for the two groups (pre-implementation (i.e., current practice) and the post-
implementation group (multimodal analgesia + VR).  Normality of the continuous study 
variables (total VR utilization time, length of stay in PACU, and total opioid consumption 
converted as MME) for the two groups (pre-implementation [i.e., current practice] and post-
implementation group [multimodal analgesia + VR]) were examined using the Shapiro-Wilk 
normality tests (Field, 2013).   
The project's primary purpose was to determine if the addition of two non-opioid 
interventions would impact the participant’s postoperative opioid consumption.  This was done 
by measuring if there was a statistically significantly difference in the event variables and the 
primary outcome variable between the pre-implementation (i.e., current practice) group and the 
post-implementation group that received both EBPs (multimodal analgesia + VR).   
Results 
The participant size for each of the study groups was: 64 (pre-implementation) and 22 
(post-implementation; multimodal analgesia + VR).  The categorical population variables of 
interest, including gender, race, ASA, and diagnosis for these two study groups are summarized 
in Table 1.  
All participants were female who underwent the robotic hysterectomy procedure. The 
majority of the participants were White in the pre-implementation group (85.9%) and the 
multimodal analgesia + VR group (77.3; Table 1).  The majority of the participants in the pre-
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implementation group (73.4%) and the multimodal analgesia + VR group (68.2%) had an ASA 
classification equal to 2 (Table 2).  For diagnosis, about one-third of the participants in the pre-
implementation group (31.3%) and multimodal analgesia + VR group (31.8%) had a cancer-
related diagnosis (Table 1). 
Table 1 
Summary (Frequency (%)) of Participants Variables (Gender, Race, ASA, and Diagnosis) 
Variable Pre (N = 64) MA + VR (N = 22) 
Gender   
  Female 64 (100)  22 (100) 
  Male 0 0 
Race   
  White 55 (85.9) 17 (77.3) 
  Hispanic 1 (1.6) 0 
  Asian 5 (7.8) 2 (9.1) 
  Other 3 (4.7) 3 (13.6) 
ASA   
  0 2 (3.1) 0 
  1 2 (3.1) 2 (9.1) 
  2 47 (73.4) 15 (68.2) 
  3 13 (20.3) 5 (22.7) 
Diagnosis   
  Cancer 20 (31.3) 7 (31.8) 
  Other 44 (68.8) 15 (68.2) 
 
The continuous participants’ variables of interest, including age and BMI for these two 
study groups are summarized in Table 2. The average age for the pre-implementation group and 
the multimodal analgesia + VR group was 58.34 (SD = 12.90) and 57.32 (SD = 10.82), 
respectively (Table 2).  The average BMI for the pre-implementation group and the multimodal 
analgesia + VR group was 27.33 (SD = 6.92), 28.86 (SD = 7.32), respectively (Table 2).   
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Table 2 
Descriptive Statistics (Mean and standard deviation) for Participant Variables (Age and BMI) 
Variable Pre (N = 64) MA + VR (N = 22) 
Age 58.34 (12.90) 57.32 (10.82) 
BMI 27.33 (6.52) 28.86 (7.32) 
 
Table 3 shows the frequency tables for summarizing the categorical event variables, 
including opioids prior to admission, preoperative pain score/level, multimodal analgesia 
administered in pre-op, pain at discharge, IV opioids administered in PACU, and oral opioids 
administered in PACU, for these two study groups.  
Almost all participants in the pre-implementation group (92.2%) and the multimodal 
analgesia + VR group (95.5%) had a low level (NRS of 5 or less) of preoperative pain prior to 
undergoing surgery (Table 3).  Similarly, almost all participants in the pre-implementation group 
(98.4%) and all participants (100%) in the post-implementation group (multimodal analgesia + 
VR) had low level of pain at discharge (NRS of 5 or less; Table 3).  
Table 3 
Summary (Frequency (%)) of Categorical Event Variables 
Variable Pre  
(N = 64) 
MA + VR  
(N = 22) 
  
Preoperative pain     
  Low pain (NRS 0-5) 59 (92.2) 21 (95.5)   
  High pain (NRS 6-10) 5 (7.8) 1 (4.5)   
Multimodal analgesia administered in Pre-op     
  No 43 (67.2) 0   
  Yes 21 (32.8) 22 (100)   
Pain at discharge     
  Low pain (NRS 0-5) 63 (98.4) 22 (100)   
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  High pain (NRS 6-10) 1 (1.6) 0   
 
Table 4 shows the results of the Fisher’s exact tests for determining if there was a 
statistical significantly difference in each categorical event variable, including pre-operative pain 
score/level, multimodal analgesia administered in pre-op, pain at discharge, between the two 
groups of interest; between pre-implementation and multimodal analgesia + VR.  According to 
Fisher’s exact tests, there was no statistically significant difference in preoperative pain (p = 
1.000) and pain at discharge (p = 1.000), between the pre-implementation group and the 
multimodal analgesia + VR group (Table 4).  However, there was a statistically significant 
difference in multimodal analgesia administered in pre-op between the pre-implementation group 
and the multimodal analgesia + VR group (p < 0.001) (Table 4). 
Table 4 
Results of Fisher’s Exact Tests 
Variable Pre vs. MA + VR 
Pre-operative pain 1.000 
Multimodal analgesia administered in pre-op < 0.001 
Pain at discharge 1.000 
 
Table 5 presents the descriptive statistics of the two continuous event variables (length of 
stay and total VR utilization time).  According to the results of Shapiro-Wilk normality tests, the 
data for length of stay for the pre-implementation group (p = 0.068) and the multimodal 
analgesia + VR group (p = 0.263) were normally distributed (Table 5). Thus, mean and standard 
deviations were used to summarize length of stay. The average time for length of stay (measured 
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in minutes) for the pre-implementation group and the multimodal analgesia + VR group was 
156.33 (SD = 65.24) and 162.32 (SD = 44.74), respectively (Table 5). 
Table 5 
Descriptive Statistics of Continuous Event Variables  
       Shapiro-Wilk 
Variable  N M SD Mdn IQR W df p 
Length of stay Pre 64 156.33 65.24 143.0 86.8 0.965 64 0.068 
 MA + VR 22 162.32 44.74 175.5 56.3 0.946 22 0.263 
VR time Pre 64 NA NA NA NA NA NA NA 
 MA + VR 22 25.64 11.30 29.0 10.0 0.851 22 0.003 
 
Primary Outcome Variable 
Table 6 presents the descriptive statistics of the primary outcome variables (total opioid 
consumption converted as MME). According to the results of Shapiro-Wilk normality tests, the 
data for total opioid consumption converted as MME for the pre-implementation group (p < 
0.001) and the multimodal analgesia + VR group (p = 0.002) were not all normally distributed 
(Table 6).  Thus, median and IQR were used to summarize total opioid consumption converted 
as MME.  The median total opioid consumption converted as MME for the pre-implementation 
group and the multimodal analgesia + VR group was 15.0 (IQR = 30.0) and 12.5 (IQR = 32.5) 
respectively (Table 6). 
Table 6 
Descriptive Statistics of the Primary Outcome Variable 
       Shapiro-Wilk 
Variable  N M SD Mdn IQR W df p 
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Opioid consumption Pre 64 20.52 22.20 15.0 30.0 0.844 64 < 0.001 
 MA + VR 22 21.00 24.48 12.5 32.5 0.836 22 0.002 
 
The results of the Mann-Whitney U tests are presented in Table 7. For the comparison 
between pre-implementation and multimodal analgesia + VR, the results of the Mann-Whitney U 
test indicated that there was no statistically significant difference in total opioid consumption 
converted as MME between pre-implementation and multimodal analgesia + VR (U = 686.50, Z 
= -0.176, p = 0.860, r = 0.019; Table 7). The median total opioid consumption converted as 
MME for the pre-implementation group and the multimodal analgesia + VR group was 15.0 
(IQR = 30.0) and 12.5 (IQR = 32.5), respectively (Table 6). 
Table 7 
Results of Mann-Whitney U tests for Differences in Total Opioid Consumption Converted as 
MME (Pre-implementation vs. MA + VR) 
 N U Z p r 
Pre vs. MA + VR 86 686.50 -0.176 0.860 0.019 
Note. U = Mann-Whitney U test statistic; z = standardized test statistic; p = p-value. r = effect 
size, computed as |z|/√𝑁, where z is the standardized test statistic and N is the number of total 
observations (Tomczak & Tomczak, 2014).  
 
Discussion and Impact 
 This DNP project compared pre- and post-implementation data for 64 and 22 
participants, respectively.  A SMART goal outlined the project’s aims—by providing virtual 
reality as a non-pharmacological intervention, can nurses decrease opioid exposure by 10% 
within the patient’s recovery period?  This project was unable to make a statistically significant 
impact on total opioid consumption in the PACU clinical setting.  However, the analysis of 
system-wide effects discovered that nursing knowledge and experience with non-opioid 
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medications and VR technology improved—a change in practice that aligns with good clinical 
habits that can transfer to different patient environments (Allen et al., 2020).   
 Initially, the assumption was that an increase in multimodal analgesia and VR techniques 
would benefit the patient’s surgical experience by lowering adverse opioid side effects.  
Although there wasn’t a statistically significant decrease in opioids, the project guided the 
stakeholders to maintain patient-centered approaches.  The patient customized their pain 
management care, provided feedback to the nurses about their preferred VR simulations, and 
decided whether to utilize the headsets after surgery as a pain management tool.  As an added 
benefit, the nurses used the VR headsets in Pre-op to distract the patients during intravenous (IV) 
catheter insertions.  In the study done by Glennon et al. (2018), VR technology was used as a 
distraction technique and decreased pain and anxiety levels during a bone marrow biopsy and 
aspiration procedure.  Thus, further research is warranted to explore the effects of VR technology 
during percutaneous needle interventions. 
 The preoperative team demonstrated a significant change in practice during the 
implementation of this project.  The post-implementation group of participants received 
multimodal analgesia 100% of the time, compared to almost a third of the time (32.8%) in the 
pre-implementation group.  The data also revealed a remarkable difference in a separate group of 
participants not initially identified in the evaluation plan.  In a group of 27 participants who 
received multimodal analgesia medications but refused to utilize the VR technology for 
numerous reasons, such as lethargy, nausea, and dizziness, the opioid consumption was 
substantially lower (13.59 MME) than the pre-implementation group (20.52 MME).  Opioid 
consumption also decreased due to ERAS medications in the study done by Cozowics et al. 
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(2019).  Therefore, this project recommends that multimodal analgesia be standard practice for 
all robotic hysterectomy patients undergoing same-day surgery.   
Limitations 
 Various factors may have influenced the results.  The evaluation plan included securing 
at least 64 participants in the post-implementation group.  Unfortunately, this project occurred 
during the COVID-19 pandemic.  Elective surgeries were canceled temporarily and approved to 
return right before the project start date.  Therefore, the surgical volume of robotic 
hysterectomies was affected, negatively impacting program participants' ad hoc selection.  The 
post-implementation group only included a total of 22 participants.  
 As previously mentioned, 27 participants refused VR technology in the PACU due to 
complaints of lethargy after general anesthesia, nausea, and dizziness.  They also denied the VR 
headset if their pain was well managed—an unexpected barrier that hindered participant 
inclusion.  Nurses did their best to minimize this limitation by promoting VR technology as a 
therapeutic intervention through patient education.  However, anesthesiologists and nurses 
should consider altering their practice to reduce the aforementioned adverse effects.  With the 
introduction of multimodal analgesia, clinicians may need to balance the administration of 
anesthetics and analgesics in addition to frontloaded pain management interventions.   
 Given the potential for significant improvement in pain management techniques, future 
EBP change projects may address using VR technology in other perioperative clinical settings, 
such as during the preoperative IV insertions or in lieu of anesthesia administration during 
minimally invasive procedures.  Nursing practice should also mimic the best practices 
recommended.  Furthermore, this project could be duplicated with an extended timeframe for 
data collection, ideally without outside factors influencing patient surgical volumes.   
A MULTIMODAL ANALGESIC VIRTUAL REALITY PROGRAM      33 
Plans for Dissemination 
Plans for regional dissemination of this DNP project began in the fall of 2020.  On 
Friday, October 9th, 2020, the DNP student presented at the organization’s first annual Virtual 
Reality Symposium hosted by the hospital’s Director of Extended Reality and Digital 
Therapeutics.  The symposium’s objectives focused on translational and implementation science 
and methods to incorporate innovative technologies at the clinical bedside.  Virtual reality 
industry leaders, various community hospital executives interested in leading technology and 
potential organization donors were present at this meeting.  The DNP student’s goals included 
presenting the results and outcomes of the DNP project and acting as a nursing leader in the 
transforming field of virtual reality.  
Organizational dissemination of the final DNP project started in November 2020.  The 
DNP student created educational content for the Acute Care Nursing Conference.  Presentations 
and educational material were organized according to the audience members in attendance and 
included information on practice transformation within the perioperative setting.   
The national plan for dissemination included submitting an abstract for podium session at 
the Western Institute of Nursing (WIN) Conference and for a poster presentation at the 
Association of peri-Operative Registered Nurses (AORN) Global Surgical Conference & 
Exposition.  Abstract submissions occurred during October 2020.  The WIN Conference is held 
in Salt Lake City from April 14-17, 2021.  The abstract considerations are expected by the 
beginning of the 2021.  The AORN Global Surgical Conference & Exposition is scheduled for 
August 7-11, 2021 in Orlando, Florida.  Abstract determinations may be considered during the 
spring season.  
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  Although several plans were in place for dissemination, the DNP student built the 
capacity for change and adaptation as the novel coronavirus impacted society.  Dependent on the 
recommendations from the CDC, conferences with large gatherings were prohibited.  Therefore, 
strategies for dissemination shifted to webinar-based platforms, digital posters, and online 
journal publications.  As a university requirement, a full-text scholarly publication is available in 
the University of St. Augustine for Health Sciences institutional repository called SOAR@USA.   
Conclusion 
The Multimodal Analgesic Virtual Reality Program’s intended purpose was to provide a 
formative answer to society’s opioid epidemic by reducing immediate postoperative opioid 
exposure and usage.  Healthcare providers had the chance to positively influence the crisis by 
providing patients with evidence-based treatments and best practices for substance abuse 
prevention (Naegle, Mitchell, Flinter, Dunphy, Vanhook, & Delaney, 2017).  Nurses, 
anesthesiologists, and surgeons worked together on this project to support the combination of 
non-opioid, multimodal analgesia and VR as a non-pharmacological intervention.  This project 
focused on an opioid-sparing culture and required a coordinated, interdisciplinary team effort to 
change actions and policies.   
Using the Model for Improvement, the DNP student acted as the nursing project lead and 
drove juxtaposed evidence-based practice changes along a timeline.  The PDSA cycle ran from 
October 2019 to December 2020 and provided the rapid cycle culture change agenda.  
Numerable variables measured pre- and post-implementation of the program to capture if the 
healthcare providers’ variation in practice contributed to the project’s success.   
There was no statistically significant difference in total opioid consumption converted as 
morphine milligram equivalents (MME) between the pre-implementation and post-
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implementation groups.  However, there was a statistically significant difference in multimodal 
analgesia administered in Pre-op between the pre-implementation and post-implementation 
groups.  Therefore, the execution of the multimodal analgesic VR program allowed for nursing 
adoption of novel evidence-based practices (EBP) and promoted the use of non-opioid and non-
pharmacological interventions.  Although the combination of multimodal analgesia and VR did 
not reduce opioid consumption, the practice of incorporating multimodal analgesia as a standard 
workflow improved. 
In conclusion, this project helped mitigate the potential for opioid abuse by providing 
clinicians other proven methods to treat pain effectively.  A formal plan for disseminating its 
results was in place to attract buy-in from stakeholders within the organization and improve 
scalability to other nursing departments.  The long-term objective remains active at the nursing 
bedside.  Clinicians continue to adopt EBPs into their everyday workflow and pave the way for 
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Figure 2. 
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Figure 6. 
Process Map Algorithm for VR Headset Criteria 
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Figure 7. 
SootheVR Instruction Pamphlet 
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Figure 8. 
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Figure 9. 
Virtual Reality Patient Log Sheet 
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Appendix A 
Table 1. Primary Research Evidence Table 
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Appendix B 
Table 2.  Summary of Systematic Reviews (SR)  
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analyzed; 23 RCTs, 
3 controlled and 
non-randomized 
clinical trials—
level of evidence 
based on the 
Cochrane 
classification.  
VR is an effective tool 
for managing both 
psychosocial and 
neurosensitive factors 
related to pain.  VR 
has demonstrated, on 
magnetic resonance 
imaging, reduced 
activation of CNS 
pain regions in the 
brain.  VR also works 
as a distraction 
mechanism, deviating 
the user’s focus away 
from pain, thus 
reducing the need for 
medication.  
VR is a proven, 
effective non-
pharmacological 
intervention for pain in 
burn patients.  It also 
benefits other 
consequences of pain, 
such as anxiety.  
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efficacy of virtual 








Centre for Review 
and Dissemination, 
Proquest 
Inclusion criteria:  
Peer-reviewed journal, 
examined effect of VR on 




Lacked intervention for 
pain, non-VR control 
group, and experimental 
design 
48 full text articles 




Cochrane risk of 
bias assessment 
tool was used for 
parallel group 
RCTs.  The tool 
was modified for 
crossover trials.    
The meta-analysis 
conducted showed 
that VR had a positive 
influence on pain 
scores.  However, its 
effects vary between 
different procedures, 
where needle studies 
and burn physical 
therapy showed the 
most benefit.  Since 
VR is a non-blindable 
intervention, bias was 
present throughout the 
review.  
Early evidence suggests 
that VR is effective for 
treating pain during 
burn physical therapy 
and needle studies.  
There is a need for 
higher-quality studies to 
validate the widespread 
adoption of VR. 
 
Legend: 
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BDENF – Base de Dados de Enfermagem 
CINAHL – Cumulative Index to Nursing & Allied Health Literature  
CNS – Central nervous system 
GRADE – Grading of Recommendations Assessment, Development and Evaluation 
LILACS – Latin American and Caribbean Health Sciences Literature 
RCT – Randomized control trial 
TRIP – Turning Research into Practice 
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Appendix C 
Project Schedule 








































































































































Meet with preceptor 
and project champions 




X X                       
Create a project 
budget 
X                        
Seek Executive 
Leadership Approval 
 X                       
Conduct literature 
review 
X X X X                     
Prepare project 
proposal  
X X X X X X X X                 
Obtain project 
stakeholder approval 
       X X X X X             
Obtain university EBP 
committee approval 
         X               
Obtain hospital IRB 
approval 
         X               
Offer nursing 
education in-services  
         X X              




         X X              
Begin project pilot 
implementation 
          X X X X           
Begin data collection           X X X X X X         
Comprehensive 
statistical analyses 
                X X X      
Analyze efficacy of 
program 
                   X X X X X 
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and sustainability of 
program 
                    X X X X 
Disseminate learning 
to organization 
                     X X X 
Begin planning for 
next PDSA cycle 
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Appendix D 
Table 3. Evaluation Plan 












Population Patient MRN Unique assigned 
medical record 
number 
EPIC N/A Nominal N/A Pre- and Post-
intervention 
 
Age Age at start of 
intervention 
EPIC 18-100 Continuous N/A Pre- and Post-
intervention 
 
Gender Gender EPIC 0 = male, 1 = female Dichotomous N/A Pre- and Post-
intervention  
Race/Ethnicity Race/Ethnicity EPIC 0 = White, 1 = 
Hispanic, 2 = Black, 
3 = Asian, 4 = Other 
Nominal N/A Pre- and Post-
intervention 
 
BMI Body Mass Index EPIC 15-50 Continuous N/A Pre- and Post-
intervention  
ASA  American Society of 
Anesthesiologists 
Classification 






EPIC 0 = Other, 1 = 
Cancer 




Pain number using 
validated screening 
tool reported prior 
to surgery 
EPIC 0 = Low Pain (0-5), 
1 = High Pain (6-10) 





Pain number using 
validated screening 
tool 
EPIC 0 = Low Pain (0-5), 










≥ 2 oral, non-opioid 
pain medications 
given in Pre-op 







LOS - PACU Length of stay; Both 
Phase I and Phase II 
Combined in 
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Minutes 
 
VR Time Total VR utilization 
time in minutes 














PACU Phase I & II 
until discharge 











Gpower Sample Size Calculation 
 
 
 
 
 
 
